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Background: The National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (KDOQI) developed
guidelines to care for patients with chronic kidney disease (CKD). While these are disseminated through the NKF’s
website and publications, the guidelines’ usage remains suboptimal. The KDOQI Educational Committee was
formed to identify barriers to guideline implementation, determine provider and patient educational needs and
develop tools to improve care of patients with CKD.
Methods: An online survey was conducted from May to September 2010 to evaluate renal providers’ familiarity,
current use of and attitudes toward the guidelines and tools to implement the guidelines.
Results: Most responders reported using the guidelines often and felt that they could be easily implemented into
clinical practice; however, approximately one-half identified at least one barrier. Physicians and physician extenders
most commonly cited the lack of evidence supporting KDOQI guidelines while allied health professionals most
commonly listed patient non-adherence, unrealistic guideline goals and provider time-constraints. Providers
thought that the guidelines included too much detail and identified the lack of a quick resource as a barrier to
clinical implementation. Most were unaware of the Clinical Action Plans.
Conclusions: Perceived barriers differed between renal clinicians and allied health professionals; educational and
implementation tools tailored for different providers are needed.
Keywords: KDOQI, Chronic kidney disease, Guidelines, SurveyBackground
Chronic kidney disease (CKD) represents a large burden
among affected patients and on the healthcare system in
the U.S. Approximately 26 million U.S. individuals have
impaired kidney function or albuminuria [1]; the majority
of these patients also have other significant co-morbid
conditions such as diabetes mellitus, hypertension and
cardiovascular disease [2]. Patients with CKD have signifi-
cantly higher risk for hospital admissions [3-5], acute kid-
ney injury [6], and cardiovascular-related death [7].
Moreover, CKD-associated costs have increased signifi-
cantly, with CKD comprising 5.8% in 2000 to now 16% in* Correspondence: mchoi3@jhmi.edu
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reproduction in any medium, provided the or2009 of total Medicare costs. In 2009, this amounted to
$33.8 billion in Medicare expenditures, excluding Medi-
care part D [2].
Studies have shown that early recognition and treatment
of CKD can slow progression [8] to end-stage renal dis-
ease and improve overall survival among these patients
[9]. In a cohort study of 556 patients initiating dialysis, re-
ceipt of quality care in the management of CKD-related
complications prior to dialysis initiation was associated
with greater survival during the first year following dialy-
sis initiation [10]. To improve the recognition and facili-
tate management of patients with CKD, the National
Kidney Foundation (NKF) developed the Kidney Dis-
ease Outcomes Quality Initiative (KDOQI). Since its in-
ception in 1997, the KDOQI has provided clinicians
with evidence and opinion-based practice guidelinesLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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staging, mineral bone disease and anemia among others.
The KDOQI guidelines are supplemented by the Clin-
ical Action Plans which are resources that yield man-
agement recommendations based on a patient’s stage of
CKD and history of diabetes or hypertension. The Clin-
ical Action Plans provide embedded relevant informa-
tion from KDOQI guidelines. These guidelines and
tools for clinicians are disseminated through the NKF’s
website (www.kidney.org) and in print in special issues
of the American Journal of Kidney Diseases.
While the KDOQI guidelines have been available and
updated over the past decade, recognition and manage-
ment of CKD patients remain highly variable and often
suboptimal [11,12]. In a cross-sectional analysis of 198
patients with stage 4 and 5 CKD, only 10-17% of pa-
tients had achieved target blood pressures, 9-24% had
intact parathyroid hormone (PTH) levels within
recommended goal range, and 19-55% had optimal lipid
levels based on recommended targets by the KDOQI
guidelines [13]. Similar trends were observed in a large
cohort of patients from the Southern California Kaiser
Permanente organization from 2002 to 2008 [14]. To
bridge the gap between clinical practice and guideline
targets, the NKF KDOQI leadership formed an educa-
tional committee charged with identifying barriers to
guideline utilization and implementation, determining
clinician and patient educational needs, and develop-
ment of effective tools to improve the care of patients
with CKD. To that end, we conducted an online survey
to evaluate renal providers’ familiarity, current use of
and attitudes toward the KDOQI guidelines and NKF-
provided clinical tools to implement KDOQI guidelines.
The findings of this survey are to inform the KDOQI
Education Committee regarding strategies to improve
KDOQI guideline implementation.
Methods
An online survey was developed by one of the authors
(MJC), reviewed by members of the NKF KDOQI Edu-
cation Committee, and offered from May to September
2010 to all physicians, physician extenders and allied
health professionals, including nurses, dialysis techni-
cians, dietitians and social workers who were regis-
tered in the NKF professional database. The survey
was administered via Zoomerang (www.zoomerang.com)
and included 38 multiple choice and open questions
(Additional file 1). Providers were solicited twice and were
not offered any compensation.
The survey asks about the respondent’s awareness, use
and opinions regarding the presentation and content of
KDOQI guidelines. An open-ended question asked about
barriers to implementation of KDOQI guidelines in prac-
tice. Another set of questions focused on the surveyedproviders awareness, use and opinion on presentation and
content of specific guideline educational tools such as the
Clinical Action Plans and the KDOQI information located
within the NKF website. An open-ended question asked
for suggested tools that would enhance guideline imple-
mentation. Respondent demographic information was also
collected. All responses were compiled electronically by
NKF staff. For questions regarding barriers to imple-
mentation of KDOQI guidelines in daily practice and
what resources would make guidelines more useful for re-
spondents’ practice, responses were assigned into one of
15 categories by two investigators independently. Re-
sponses which were categorized discordantly were then
discussed to reach consensus. As the primary objective of
this study was to query renal providers, data from re-
sponders who did not self-identify as nephrologists or
renal allied health professionals were excluded. Renal pro-
viders were subsequently categorized into two groups: 1)
clinicians including nephrologists, nurse practitioners and
physician assistants; and 2) allied health professionals in-
cluding registered nurses, social workers/case managers,
dietitians/nutritionists, pharmacists and dialysis tech-
nicians. We also evaluated differences between neph-
rologists and nurse practitioners/physician assistants.
Comparisons between the groups were performed using
Fischer’s exact test and chi-square test, as appropriate. All
statistical analyses were performed using Stata version
11.2 (StataCorp, College Station, TX).
Results
The survey was sent to 16,323 providers. Of 951 health
care providers who completed the survey, 71 resided
outside of the U.S., 218 did not specify a subspecialty or
did not respond to this question, and 59 self-identified
as non-renal providers and were therefore excluded. Of
the remaining 600 respondents who self-identified as
renal healthcare providers, 160 were physicians, 49 were
nurse practitioners/physician assistants, and 391 were al-
lied health professionals, including registered nurses (n =
167), dietitians (n = 176), and other professionals (n = 48).
The demographic and practice characteristics of the renal
healthcare providers are summarized in Table 1.
Table 2 displays responses regarding use of the
KDOQI guidelines stratified by renal providers. While
78% of all providers reported using the KDOQI guide-
lines in their practice, the proportion of physicians and
physician extenders reporting often using these guide-
lines was lower compared to allied health professionals
(69% vs. 83%, respectively; P < 0.001). Compared with
physician extenders, fewer physicians reported using the
KDOQI guidelines often (92% vs. 62%, respectively;
p < 0.01) and at least once a month (65% vs, 41%, respec-
tively; P = 0.01). Among nephrologists, the three KDOQI
guidelines most commonly used within three months of
Table 1 Characteristics of renal survey participants
No. of respondents Providers Allied health professionals
Number of respondents 600 209 391
Profession, n (%) 160 (77) Physicians 167 (43) Registered Nurses
49 (24) Physician Extenders 176 (45) Dietitians
48 (12) Others*
No. of years in practice, n (%) 424
<6 years 85 (20) 43 (20) 42 (11)
6 years or longer 339 (70) 105 (50) 234 (60)
Practice settings, n (%) 596
Clinic 40 (7) 19 (9) 21 (5)
Dialysis unit 276 (46) 21 (10) 255 (65)
Hospital 100 (17) 33 (16) 67 (17)
Private practice 57 (10) 55 (26) 2 (1)
University 67 (11) 58 (28) 9 (2)
Other 56 (9) 21 (10) 35 (9)
No. of patients seen per week, n (%) 578
0-50 214 (37) 73 (36) 141 (38)
51-100 193 (33) 72 (35) 121 (32)
101-150 120 (21) 40 (19) 80 (22)
>150 51 (9) 20 (10) 31 (8)
* Others include social workers (n = 17), dialysis technicians (n = 11), pharmacists (n = 8), and participants who responded “Other” for their profession (n = 12).
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hemodialysis adequacy (45%). Among physician ex-
tenders, the top three KDOQI guidelines used within
three months of the survey were mineral bone disease
(82%), anemia (77%), and CKD evaluation/ hypertensionTable 2 Responses to questions inquiring about KDOQI use b
Questions




How often do you look up a specific KDOQI guideline topic or
recommendation?
At least once a month
Less than once a month or never








KDOQI, Kidney Disease and Outcomes Quality Initiative.(55%) (Figure 1). In contrast, the three KDQOI guidelines
most commonly used in the three months prior to the
survey among allied health professionals were mineral
bone disease (70%), hemodialysis adequacy (51%), and nu-









466 (78) 144 (69) 322 (83)
107 (18) 51 (24) 56 (14)
25 (4) 14 (7) 11 (3) <0.001
597
281 (47) 99 (47) 182 (47)
316 (53) 110 (53) 206 (53) 0.82
593
129 (22) 56 (27) 73 (19)
384 (65) 120 (58) 264 (68)
80 (13) 30 (15) 50 (13) 0.04
596
412 (69) 142 (68) 270 (70)
132 (22) 43 (21) 89 (23)
52 (9) 24 (11) 28 (7) 0.20
Figure 1 KDOQI Guidelines Most Commonly Used by Renal Providers. The proportions of respondents among physicians (light blue),
physician extenders (medium blue) and allied health professionals (dark blue) for each KDOQI guideline topic are shown. P-values are detailed for
topics in which there were significant differences in the proportion of respondents between the two groups.
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guidelines pertaining to hemodialysis adequacy and nutri-
tion and less likely to have used the KDOQI guidelines re-
garding anemia, CKD evaluation, hypertension, peritoneal
dialysis, and hyperlipidemia within the 3 months prior to
completing the survey.
Of the renal providers, 67% thought that the KDOQI
guidelines were presented with the correct amount of in-
formation. A similar proportion of nephrologists and
physician extenders felt that the guidelines provided too
much detail (15%). A greater proportion of these clini-
cians, however, reported that the guidelines provided too
much detail compared with allied health professionals
(27% vs. 19%, respectively; P = 0.04). However, renal pro-
viders felt that the KDOQI guidelines could be easily
adapted to their clinical practice (69%).
Among the fourteen clinicians who reported rarely or
never having used the KDOQI guidelines, 28% felt that
they had insufficient time to read the guidelines or sum-
mary information, 21% could not find information they
needed quickly, 14% practiced in settings with their own
algorithms and guidelines, and 64% did not agree with the
KDOQI guidelines. Among the eleven allied health pro-
fessionals who reported rarely or never having used
the KDOQI guidelines, 54% were not familiar with the
KDOQI guidelines and felt that they did not havesufficient time to read the guidelines. In addition, 18%
reported being unable to find needed information quickly
within the guidelines and reported having algorithms and
guidelines within their own practice or unit; only 9% did
not agree with the KDOQI guidelines.
When participants were asked to list barriers, if any, to
the implementation of KDOQI guidelines to clinical
practice, 46% of clinicians and 56% of allied health pro-
fessionals identified no barriers (P = 0.03). Among bar-
riers listed, the most common barrier perceived by
physicians was the lack of evidence supporting the
KDOQI guidelines (38%), followed distantly by the
guidelines not being applicable to their patients (13%)
(Figure 2). Compared to physician extenders and allied
health professionals, a larger proportion of nephrologists
cited lack of evidence and too much influence from in-
dustry as barriers to the implementation of the KDOQI
guidelines. Among physician extenders, the most com-
mon barriers perceived were outdated guidelines (18%),
lack of integration of the guidelines into their practice
(14%), and provider time-constraints (14%). Among al-
lied health professionals, the most common perceived
barriers were patient non-adherence, unrealistic guide-
lines and provider time-constraints. Compared with phy-
sicians and physician extenders, a greater proportion of
allied health professionals listed the lack of a quick
Figure 2 Barriers to the Implementation of KDOQI Guidelines. The proportions of respondents among physicians (light blue), physician
extenders (medium blue) and allied health professionals (dark blue) for each barrier are shown. P-values are detailed for barriers in which there
were significant differences in the proportion of respondents between the two groups.
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KDOQI guidelines.
To assess renal providers’ perceptions and use of the
NKF’s Online Clinical Action Plans to facilitate translation
of KDOQI guidelines into practice, respondents were
queried regarding these tools, and the results are shownTable 3 Responses to questions inquiring about the NKF clini
Questions
Are you aware of NKF’s online Clinical Action Plans?
No
Yes








If you use them, the Clinical Action Plans are presented with the




NKF, National Kidney Foundation; KDOQI, Kidney Disease and Outcomes Quality Iniin Table 3. The majority of renal healthcare providers
were not aware of the Clinical Action Plans, with a greater
proportion of allied health professionals unaware of these
tools compared to physicians and physician extenders
(78% vs. 71%, respectively; P = 0.05). Moreover, the major-









449 (75) 148 (71) 301 (78)
146 (25) 61 (29) 85 (22) 0.05
542
14 (3) 7 (4) 7 (2)
51 (9) 18 (10) 33 (9)
477 (88) 160 (86) 317 (89) 0.43
128
64 (50) 25 (51) 39 (49)
56 (44) 18 (37) 38 (48)
8 (6) 6 (12) 2 (3) 0.07
121
25 (21) 13 (29) 12 (16)
92 (76) 31 (69) 61 (80)
4 (3) 1 (2) 3 (4) 0.21
tiative.
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with physician extenders, physicians were slightly more
likely to have rarely or never used the Clinical Action
Plans (80% vs. 89%, respective; P = 0.01) but were other-
wise similar in their response to the other questions re-
garding the Clinical Action Plans. Among the minority of
respondents who had previously utilized the Clinical Ac-
tion Plans, approximately one-half reported that they were
easy to access, and 76% were neutral when asked whether
the Clinical Action Plans were presented with the correct
amount of information.
Participants were also asked to list tools that they
thought would facilitate the implementation of KDOQI
guidelines into clinical practice. Among 218 renal pro-
viders who responded to this question, the most common
tool suggested by providers was summary guidelines
(Figure 3). A greater proportion of physicians, compared
with physician extenders and allied health professionals,
listed evidence-based guidelines (26% vs. 6% and 2%, re-
spectively; P < 0.01) as a potential tool to improve
implementation of KDOQI guidelines into clinical practice.
In contrast, a larger proportion of physician extenders sug-
gested personal device applications as potential tools for
guideline implementation compared to physicians and al-
lied health professionals (18% vs. 6% and 1%, respectively;Figure 3 Suggested Tools for Improving the Implementation of KDOQ
(light blue), physician extenders (medium blue) and allied health profession
detailed for suggested tools in which there were significant differences inP < 0.01). In addition, fewer physicians and physician ex-
tenders compared with allied health professionals suggested
materials geared for non-physician providers (1% vs. 8%, re-
spectively; P = 0.03) and patient education materials (2% vs.
9%, respectively; P = 0.05) as potential tools.
Discussion
This report is the first to evaluate diverse nephrology
health care providers’ current use and perceptions of the
NKF KDOQI guidelines which have assumed the role of
primary national documents and informs the “standard
of care” for individuals with CKD in the U.S. Such
knowledge will help inform the NKF KDOQI Edu-
cational Committee and other guiding institutions in
nephrology determine renal providers’ current needs in
order to provide the necessary knowledge to improve
outcomes in patients with CKD. In this survey, we found
that the majority of renal providers reported using the
KDOQI guidelines often and felt that the KDOQI guide-
lines could be easily implemented into clinical practice.
However, approximately one-half of respondents identi-
fied at least one translational barrier.
Several studies evaluating the use of clinical practice
guidelines have suggested that provider adoption of guide-
lines in clinical practice is relatively low, particularly amongI Guidelines. The proportions of respondents among physicians
als (dark blue) for each suggested tool are shown. P-values are
the proportion of respondents between the two groups.
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tice guidelines was often attributed to various barriers, in-
cluding factors related to the guidelines themselves and to
provider and patient perceptions and behaviors [15]. When
obstacles to clinical implementation were identified among
responders of our survey, physicians, in particular, most
frequently cited the lack of evidence supporting KDOQI
guidelines while allied health professionals most commonly
listed patient non-adherence, unrealistic goals and provider
time-constraints. Most of these barriers were previously de-
scribed in the systematic review of barriers to physician ad-
herence to clinical practice guidelines by Cabana and
colleagues [15]. In this review, lack of physician awareness,
familiarity and agreement with specific guidelines were
among the physician-related barriers contributing to non-
adherence with clinical practice guidelines. While most
renal providers in our study were aware of KDOQI guide-
lines, the great majority were not aware of one the NKF’s
tools to implement guidelines, the Clinical Action Plans.
Moreover, the lack of agreement with specific guidelines
appears to be relevant among renal physicians and phys-
ician extenders and may be related to the fact that the older
KDQOI guidelines are largely based on observational data.
Indeed, Strippoli and colleagues have poignantly demon-
strated that the field of nephrology had the lowest number
of randomized clinical trials between 1966 and 2002 among
all other internal medicine subspecialties.[18] Furthermore,
the quality of trial reporting in nephrology was poor with a
significant number of studies lacking sufficient information
on the masking process and failing to conduct “intention-
to-treat analysis.” These observations are important as
studies in other fields show that adherence to guidelines is
greater when they are supported by evidence from random-
ized clinical trials [16]. This has recently been demon-
strated within nephrology by the evolution of anemia
management in patients with CKD based on recent ran-
domized clinical trials of erythropoiesis-stimulating agents
[19-21], emphasizing the importance of well-conducted tri-
als in informing national guidelines and influencing pro-
vider perceptions of their credibility.
An additional potential barrier to the adoption of clin-
ical practice guidelines previously reported among physi-
cians is related to the guidelines themselves, with at
least 10% of participants stating that guidelines are not
easy to use, cumbersome, and confusing [15]. In our sur-
vey, a notable proportion of renal healthcare providers
thought that the KDOQI guidelines included too much
detail, and respondents cited the lack of a quick resource
for the guidelines as a barrier to the clinical implementa-
tion of KDOQI guidelines. This may also be related to
provider time-constraints which were also cited as a bar-
rier by survey respondents. To address these particular
barriers, several tools were suggested by survey respon-
dents, with guideline summaries being the most commontool suggested. The NKF has also provided the Clinical
Action Plans on its website to facilitate implementation of
the KDOQI guidelines; unfortunately, most renal
healthcare providers surveyed were unaware of these on-
line tools. Moreover, of those who had previously used the
Clinical Action Plans, only half reported that they were
easy to access. This suggests that approaches to improve
awareness and utilization of available clinical implementa-
tion tools among providers are needed. In addition, stud-
ies to determine the efficacy of such tools are needed.
While clinical practice guidelines assimilate the large
volume of new scientific information into specific, clinic-
ally meaningful recommendations and to ultimately im-
prove quality of care for patients with CKD [22], several
obstacles hinder the application of these guidelines into
clinical practice. Several endeavors to address these bar-
riers and improve integration of guidelines into practice
have been developed, and more are underway. The most
notable endeavor has been the automatic reporting of esti-
mated glomerular filtration rates (eGFR); however, early
assessments of this initiative have underscored the need
for provider education. While eGFR reporting has led to
improved recognition of patients with CKD and increased
numbers of nephrology referrals [23], a chart review of
nearly 15,000 primary care patients in the Bronx Veterans
Affairs Medical Center showed that eGFR reporting alone
had no significant effect on the actual care of patients
with stage 3 CKD [24]. While tools geared for educating
renal providers such as those suggested by survey respon-
dents play a role in helping implement guidelines, other
strategies are required. Clinical decision support systems
have been endorsed by the Institute of Medicine to im-
prove implementation of guidelines [25]. Studies within
the Veterans Affairs using clinical decision support sys-
tems that present clinical reminders to healthcare pro-
viders about general appropriate management of chronic
conditions such as hypertension and diabetes have shown
improved adherence with guidelines [26]. We have shown
that there are variations in KDOQI topics most often used
by specific providers and in the perceived barriers be-
tween various renal providers in our study. Therefore, it is
likely that such systems will need tailoring based on the
type of provider and his/her role in the care of patients
with CKD as well as the provider work setting. Matchar
and colleagues conducted a multidisciplinary needs as-
sessment to develop a conglomerate of tools that could
aid in the identification of patients with CKD, develop-
ment and implementation of tailored management plans
[27]. These were based on four clinical practice con-
texts: 1) primary care providers with a hectic practice
but no significant knowledge of CKD issues; 2) primary
care providers practicing in a rural area with limited ac-
cess to nephrology consultation; 3) renal physicians
overwhelmed with patients but with good rapport with
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suboptimal communication with primary providers and
primarily received referrals for very advanced CKD. The
investigators’ efforts in collaboration with the Renal
Physicians Association and the National Institutes of
Health National Kidney Disease Education Program
culminated in the Advanced CKD Patient Management
Toolkit (http://www.renalmd.org/RPA-Advanced-CKD-
Patient-Management-Toolkit) which was pilot-tested in
two nephrology clinical practices in 2005, further re-
fined and tested in 10 nephrology clinical practices, and
was most recently revised in 2009 to help providers car-
ing for patients with CKD, particularly nephrologists,
implement clinical practice guidelines into their prac-
tice [28]. While geared for nephrologists, the tookit in-
cludes several assessment and implementation tools
that may be useful for primary care providers and pa-
tients as well. In the United Kingdom, CKD-focused
clinical decision support systems and electronic patient
tools have been developed and put into practice [29].
Prospective studies are needed, however, to determine
whether these efforts translate into improved outcomes
in patients with CKD.
The findings reported in our paper should be inter-
preted in the context of its limitations. A major limita-
tion is the low overall response rate of 5.8%. Although
this response rate may be due to technical issues with
survey delivery, such as invalid email addresses, we
cannot rule out other factors related to non-response
that may have biased our findings. In addition, we were
unable to determine the response rate among U.S.
renal providers specifically as data on the profession of
non-responders were unknown. Thirdly, the online
survey was sent only to users of the NKF website. Due
to the focused data obtained through the survey and
the limited data available on U.S. renal providers, we
were unable to determine whether survey responders
were comparable to non-responders. Therefore, self-
reported practices and attitudes toward the KDOQI
guidelines and tools may not be generalizable to all
U.S. renal healthcare providers. These survey results,
however, included responses from various types of pro-
viders involved in the care of patients with CKD and
sheds light on some aspects of the KDOQI guidelines
and related tools that could help professional associa-
tions improve delivery of educational and implementa-
tion tools to specific subgroups of renal providers. We
excluded individuals who self-identified as having sub-
specialties other than nephrology; therefore, a thor-
ough assessment of the utilization and opinions of the
KDOQI guidelines of other subspecialties, especially
primary care providers who bear the burden of CKD
care, are still needed in order to assess the educational
needs of these clinicians.Conclusions
In summary, the KDOQI guidelines are commonly used
by renal healthcare providers; however, barriers to the im-
plementation of KDOQI guidelines into clinical practice
exist. The topics of interest and the perceived barriers dif-
fer among physicians, physician extenders and allied health
professionals; therefore, educational and implementation
tools tailored for different providers are needed.
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